Discrimination between parkinsonian syndrome and essential tremor using artificial neural network classification of quantified DaTSCAN data
暂无分享,去创建一个
Stephen Hogg | D. Hamilton | David Hamilton | Adrian List | Timothy Butler | Martin Cawley | M. Cawley | A. List | Stephen Hogg | T.W. Butler
[1] S. E. Kim,et al. SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity. , 1999, Neurological research.
[2] J. Unterrainer,et al. [123I] β-CIT binding and SPET compared with clinical diagnosis in parkinsonism , 2000 .
[3] Rosemary J Morton,et al. Comparison of different methods of DatSCAN quantification , 2005, Nuclear medicine communications.
[4] H. Hooper,et al. Artificial neural networks that use single-photon emission tomography to identify patients with probable Alzheimer's disease , 1994, European Journal of Nuclear Medicine.
[5] L. Deecke,et al. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] J. Unterrainer,et al. Measuring the progression of idiopathic Parkinson's disease with [123I] β-CIT SPECT , 2000, Journal of Neural Transmission.
[7] B L Holman,et al. A neural network classifier for cerebral perfusion imaging. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] D J Wyper,et al. Correlation of Parkinson's disease severity and duration with 123I‐FP‐CIT SPECT striatal uptake , 2000, Movement disorders : official journal of the Movement Disorder Society.
[9] E. Wolters,et al. FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson ’ s disease , 2001 .
[10] S. Gacinovic,et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group , 2000, Movement disorders : official journal of the Movement Disorder Society.
[11] Z Walker,et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand , 2002, Journal of neurology, neurosurgery, and psychiatry.
[12] Eileen O. Smith,et al. Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease , 1995, Annals of neurology.
[13] L. Friberg,et al. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[14] J. Unterrainer,et al. [123I] beta-CIT binding and SPET compared with clinical diagnosis in parkinsonism. , 2000, Nuclear medicine communications.
[15] P J Slomka,et al. Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] Rosemary J Morton,et al. Variation of DaTSCAN quantification between different gamma camera types , 2005, Nuclear medicine communications.
[17] M. Canesi,et al. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy , 2003, Neurological Sciences.
[18] S. Asenbaum,et al. [123I]β-CIT and SPECT in essential tremor and Parkinson's disease , 1998, Journal of Neural Transmission.
[19] P Slomka,et al. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] J D Speelman,et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[21] N. Verhoeff,et al. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] J. Booij,et al. [123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease , 2001, Journal of Neural Transmission.
[23] Diagnostic performance of a 3-D automated quantification method of dopamine D2 receptor SPECT studies in the differential diagnosis of parkinsonism , 2005, Nuclear medicine communications.